Ryvu Therapeutics SA
WSE:RVU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
PL |
|
Gattaca PLC
LSE:GATC
|
UK |
|
R
|
Raba Jarmuipari Holding Nyrt
BET:RABA
|
HU |
|
F
|
FACB Industries Incorporated Bhd
KLSE:FACBIND
|
MY |
|
C
|
Carrefour SA
DUS:CAR
|
FR |
|
AJ Lucas Group Ltd
ASX:AJL
|
AU |
|
N
|
NNIT A/S
CSE:NNIT
|
DK |
|
F
|
First Milling Company SJSC
SAU:2283
|
SA |
|
F
|
Freeport-McMoRan Inc
BMV:FCX
|
US |
|
Inscobee Inc
KRX:006490
|
KR |
|
Tan Chong International Ltd
HKEX:693
|
HK |
|
A
|
AIA Engineering Ltd
NSE:AIAENG
|
IN |
|
Me Today Ltd
NZX:MEE
|
NZ |
|
US Global Investors Inc
NASDAQ:GROW
|
US |
|
Applied Industrial Technologies Inc
NYSE:AIT
|
US |
Bankruptcy Probability
Ryvu Therapeutics SA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ryvu Therapeutics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PL |
R
|
Ryvu Therapeutics SA
WSE:RVU
|
531.7m PLN |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
978.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
134.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
309.7B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
35.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
29.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ryvu Therapeutics SA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ryvu Therapeutics SA has total debt of 78.1m PLN. This includes both short-term (0 PLN) and long-term (78.1m PLN) debt.
You can find a full breakdown on its Balance Sheet.
